Tremor Monitoring Device

Parkinson's Disease Clinical Trial

Official title:

Tremor Monitoring Device

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02523807
• Other study ID #: 0486-14-RMB
• Status: Completed
• Phase: N/A
• First received: August 10, 2015
• Last updated: October 30, 2017
• Start date: September 2015
• Est. completion date: October 30, 2017

Study information

• Verified date: October 2017
• Source: Rambam Health Care Campus
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients with tremor may have varying degrees of tremor at different times. The amplitude and frequency of tremor may change. The investigators observational study is intended to document this tremor.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: October 30, 2017
• Est. primary completion date: October 30, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with tremor due to Parkinson's disease or Essential tremor

Exclusion Criteria:

• Severe dementia

Related Conditions & MeSH terms

• Essential Tremor
• Parkinson Disease
• Parkinson's Disease
• Tremor

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Rambam Health Care Campus	Technion, Israel Institute of Technology

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maximum linear acceleration of the forearm.	We will measure linear acceleration of the forearm in meter per second squared.	Linear acceleration of the forearm will be measured for 15-60 minutes.
Secondary	Maximum angular velocity of the forearm.	We will measure angular velocityof the forearm in degrees per second.	Maximum angular velocity of the forearm will be measured for 15-60 minutes.